Skip to main content
Yu-Wei Chen, MD, Oncology, La Jolla, CA

Yu-WeiChenMDMS

Oncology La Jolla, CA

Genitourinary Oncology

I am a medical oncologist treating prostate, kidney, bladder, and testicular cancer at the University of California San Diego

Dr. Chen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Chen's full profile

Already have an account?

  • Office

    3855 Health Sciences Dr
    La Jolla, CA 92037
    Phone+1 858-657-7876

Summary

  • Yu-Wei Chen, MD, MS, is a board-certified medical oncologist who subspecializes in genitourinary (GU) oncology, treating prostate, kidney, bladder and testicular cancers. As a GU medical oncologist, Dr. Chen is trained in using systemic therapies (e.g., immunotherapy, targeted therapy, hormonal therapy, and chemotherapy) to treat patients with GU malignancies.

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2020 - 2023
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 2016 - 2019
  • Harvard T. H. Chan School of Public Health
    Harvard T. H. Chan School of Public HealthMS, Epidemiology, 2013 - 2015
  • National Cheng Kung University College of Medicine
    National Cheng Kung University College of MedicineClass of 2012, MD

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2019 - 2025
  • MA State Medical License
    MA State Medical License 2019 - 2024
  • TN State Medical License
    TN State Medical License 2020 - 2023
  • OH State Medical License
    OH State Medical License 2016 - 2019
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • ASCO Young Investigator Award Conquer Cancer Foundation, 2022
  • ASCO Merit Award Conquer Cancer Foundation, 2022
  • Methods in Clinical Cancer Research Workshop Participant ASCO/AACR, 2021
  • Join now to see all

Publications & Presentations

PubMed

Authored Content

  • Treatment Options After First-Line Immune Checkpoint Inhibitor Combinations in Metastatic Renal Cell CarcinomaDecember 2023
  • Adjuvant Pembrolizumab After Nephrectomy in Renal Cell Carcinoma: Embracing the Promises and Acknowledging the UncertaintiesFebruary 2022

Press Mentions

  • Advanced Kidney Cancer Research: Insights from IKCS 2021
    Advanced Kidney Cancer Research: Insights from IKCS 2021December 4th, 2021

Professional Memberships

Other Languages

  • Chinese (Mandarin), Taiwanese